158 related articles for article (PubMed ID: 29600356)
1. Radiotherapy for Esophageal Adenocarcinoma.
Kwong DLW; Lam KO
Methods Mol Biol; 2018; 1756():7-17. PubMed ID: 29600356
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for Esophageal Adenocarcinoma.
Lam KO; Kwong DLW
Methods Mol Biol; 2018; 1756():19-34. PubMed ID: 29600357
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction.
Yaremko BP; Palma DA; Erickson AL; Pierce G; Malthaner RA; Inculet RI; Dar AR; Rodrigues GB; Yu E
Radiat Oncol; 2013 Feb; 8():33. PubMed ID: 23398690
[TBL] [Abstract][Full Text] [Related]
4. Combined taxane-based chemotherapy and intensity-modulated radiotherapy with simultaneous integrated boost for gastroesophageal junction adenocarcinoma.
Spatola C; Tocco A; Pagana A; Milazzotto R; Luigi R; Salamone V; Militello C; Migliore M; Foti PV; Cataldo AD; Acquaviva G; Privitera G
Future Oncol; 2018 Mar; 14(6s):47-51. PubMed ID: 29664354
[TBL] [Abstract][Full Text] [Related]
5. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
6. Cancer of the oesophagus and lymph nodes management in the neoadjuvant or definitive radiochemotherapy setting.
Bourbonné V; Pradier O; Schick U; Servagi-Vernat S
Cancer Radiother; 2019 Oct; 23(6-7):682-687. PubMed ID: 31492540
[TBL] [Abstract][Full Text] [Related]
7. Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival.
Goense L; van der Sluis PC; van Rossum PSN; van der Horst S; Meijer GJ; Haj Mohammad N; van Vulpen M; Mook S; Ruurda JP; van Hillegersberg R
J Surg Oncol; 2017 Jun; 115(7):812-820. PubMed ID: 28267212
[TBL] [Abstract][Full Text] [Related]
8. Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer.
Tomasello G; Ghidini M; Barni S; Passalacqua R; Petrelli F
Expert Rev Clin Pharmacol; 2017 Jun; 10(6):649-660. PubMed ID: 28349718
[TBL] [Abstract][Full Text] [Related]
9. Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction.
Sunde B; Ericson J; Kumagai K; Lundell L; Tsai JA; Lindblad M; Rouvelas I; Friesland S; Wang N; Nilsson M
Dis Esophagus; 2016 Jul; 29(5):442-7. PubMed ID: 25809837
[TBL] [Abstract][Full Text] [Related]
10. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
11. Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction.
Zhao Q; Li Y; Wang J; Zhang J; Qiao X; Tan B; Tian Y; Shi G; Xu Q; Li R; Liu Y; Yang P
Am J Med Sci; 2015 Jun; 349(6):472-6. PubMed ID: 25996101
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
[TBL] [Abstract][Full Text] [Related]
13. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).
Penniment MG; De Ieso PB; Harvey JA; Stephens S; Au HJ; O'Callaghan CJ; Kneebone A; Ngan SY; Ward IG; Roy R; Smith JG; Nijjar T; Biagi JJ; Mulroy LA; Wong R;
Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):114-124. PubMed ID: 29248399
[TBL] [Abstract][Full Text] [Related]
14. Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy.
Nabavizadeh N; Shukla R; Elliott DA; Mitin T; Vaccaro GM; Dolan JP; Maggiore RJ; Schipper PH; Hunter JG; Thomas CR; Holland JM
Dis Esophagus; 2016 Aug; 29(6):614-20. PubMed ID: 26043837
[TBL] [Abstract][Full Text] [Related]
15. Staging of adenocarcinoma of the gastroesophageal junction.
Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Offerhaus GJ; Ruurda JP; van Hillegersberg R
Eur J Surg Oncol; 2016 Mar; 42(3):400-6. PubMed ID: 26777127
[TBL] [Abstract][Full Text] [Related]
16. Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis.
Burstow M; Kelly T; Panchani S; Khan IM; Meek D; Memon B; Memon MA
Dis Esophagus; 2009; 22(6):519-25. PubMed ID: 19302213
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
[TBL] [Abstract][Full Text] [Related]
18. Management of Dysphagia in Esophageal Adenocarcinoma Patients Undergoing Neoadjuvant Chemotherapy: Can Invasive Tube Feeding be Avoided?
Cools-Lartigue J; Jones D; Spicer J; Zourikian T; Rousseau M; Eckert E; Alcindor T; Vanhuyse M; Asselah J; Ferri LE
Ann Surg Oncol; 2015; 22(6):1858-65. PubMed ID: 25476030
[TBL] [Abstract][Full Text] [Related]
19. Treatment approaches to esophagogastric junction tumors.
Kurokawa Y; Sasako M; Doki Y
Dig Surg; 2013; 30(2):169-73. PubMed ID: 23867594
[TBL] [Abstract][Full Text] [Related]
20. [Radiotherapy in cancers of the oesophagus, the gastric cardia and the stomach].
Créhange G; Huguet F; Quero L; N'Guyen TV; Mirabel X; Lacornerie T
Cancer Radiother; 2016 Sep; 20 Suppl():S161-8. PubMed ID: 27523409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
